Lung lifesci 2.0
Chronic lung diseases like asthma and chronic obstructive pulmonary disease change through time, and are now recongised has having a number of disease sub-types. We're developing patent pending hardware and software algorithms to widen access to quality diagnostics. Our innovations will lower the costs of tests by at least an order of magnitude, making it possible to test more frequently and in situations that were not possible before. A bit like what blood glucose testing is for insulin-dependant diabetes, but for lung diseases. This will help doctors personalise treatment plans for their patients, and give feedback to people with these diseases to help them self-manage their disease.
Member count: 1-10
Phone: +44 1223 800445
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 16.12.2021 | Introducin... | As part of our ‘12 Days of Sca... | - | - | technation... |
| 13.12.2021 | Early-stag... | Early-stage tech companies fro... | - | - | cambridgen... |
| 13.12.2021 | Early-stag... | Early-stage tech companies fro... | - | - | cambridgen... |
| 13.12.2021 | Early-stag... | Early-stage tech companies fro... | - | - | cambridgen... |
| 13.12.2021 | Early-stag... | Early-stage tech companies fro... | - | - | cambridgen... |